Question

A patient already on salbutamol and ipratropium continues to have nocturnal exacerbations of asthma. What is the next step?

• A. Oral corticosteroids
• B. Montelukast
• C. LABA plus inhalation steroids
• D. Increase the dose of salbutamol

Hint:

Asthma with persistent or nocturnal symptoms needs controller therapy, commonly inhaled corticosteroid with LABA.

Answer 1

The Correct Option is C

Step 1: Understanding the Question:
The patient is currently using Short-Acting Beta-Agonists (SABA - Salbutamol) and Short-Acting Muscarinic Antagonists (SAMA - Ipratropium). This is essentially symptomatic "rescue" therapy. Persistent nocturnal symptoms indicate that the underlying inflammation is not controlled.
Step 2: Detailed Explanation:

Asthma Step-wise Management (GINA Guidelines): Asthma is a chronic inflammatory disease. If a patient requires rescue medication more than twice a week or has nocturnal symptoms, they need "Controller" therapy.

Inhaled Corticosteroids (ICS): This is the cornerstone of asthma management. ICS addresses the airway inflammation that causes hyper-responsiveness.

Long-Acting Beta-Agonists (LABA): Adding a LABA (like Salmeterol or Formoterol) to an ICS provides superior bronchodilation over a 12-to-24-hour period, which is particularly effective for controlling nocturnal symptoms.

Combination Therapy: GINA guidelines now emphasize the use of ICS-Formoterol as both a preferred controller and reliever for many steps. Moving from SABA/SAMA to an ICS/LABA combination is the standard "step up" for uncontrolled asthma.

Why not others? Oral corticosteroids (Option A) are for severe acute exacerbations, not long-term control. Increasing Salbutamol (Option D) only treats symptoms briefly and increases the risk of side effects and tolerance.

Step 3: Final Answer:
The appropriate next step for uncontrolled asthma with nocturnal symptoms is to start a controller regimen, specifically a combination of Inhaled Corticosteroid (ICS) and a Long-Acting Beta-Agonist (LABA).